Snapshots

Search

Search managers or tickers

MLTX Moonlake Immunotherapeutics

held 3 mo · 1 quarters on record · no longer held MLTX across all managers
Position over time
PeriodShares% of portfolioActivityValue
Q1 2024 87,500 0.12% NEW $4M